1. Home
  2. GOSS vs ESOA Comparison

GOSS vs ESOA Comparison

Compare GOSS & ESOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • ESOA
  • Stock Information
  • Founded
  • GOSS 2015
  • ESOA 2006
  • Country
  • GOSS United States
  • ESOA United States
  • Employees
  • GOSS N/A
  • ESOA N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • ESOA Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • GOSS Health Care
  • ESOA Industrials
  • Exchange
  • GOSS Nasdaq
  • ESOA Nasdaq
  • Market Cap
  • GOSS 203.3M
  • ESOA 172.9M
  • IPO Year
  • GOSS 2019
  • ESOA 2006
  • Fundamental
  • Price
  • GOSS $1.16
  • ESOA $10.02
  • Analyst Decision
  • GOSS Strong Buy
  • ESOA Strong Buy
  • Analyst Count
  • GOSS 4
  • ESOA 1
  • Target Price
  • GOSS $7.75
  • ESOA $21.00
  • AVG Volume (30 Days)
  • GOSS 1.6M
  • ESOA 286.7K
  • Earning Date
  • GOSS 05-15-2025
  • ESOA 05-12-2025
  • Dividend Yield
  • GOSS N/A
  • ESOA 0.30%
  • EPS Growth
  • GOSS N/A
  • ESOA 81.20
  • EPS
  • GOSS N/A
  • ESOA 1.09
  • Revenue
  • GOSS $124,590,000.00
  • ESOA $367,911,284.00
  • Revenue This Year
  • GOSS N/A
  • ESOA $9.95
  • Revenue Next Year
  • GOSS $190.37
  • ESOA N/A
  • P/E Ratio
  • GOSS N/A
  • ESOA $9.21
  • Revenue Growth
  • GOSS N/A
  • ESOA 4.62
  • 52 Week Low
  • GOSS $0.50
  • ESOA $6.50
  • 52 Week High
  • GOSS $1.55
  • ESOA $19.83
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 55.35
  • ESOA 55.50
  • Support Level
  • GOSS $1.09
  • ESOA $9.79
  • Resistance Level
  • GOSS $1.20
  • ESOA $10.97
  • Average True Range (ATR)
  • GOSS 0.09
  • ESOA 0.70
  • MACD
  • GOSS 0.00
  • ESOA 0.08
  • Stochastic Oscillator
  • GOSS 69.01
  • ESOA 69.35

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About ESOA Energy Services of America Corporation

Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.

Share on Social Networks: